所有图片(1)

主要文件

COO原产地证书/COA分析证书

查看所有文档

SML0709

GSK-J1

Name: GSK-J1
Brand: SIGMA

≥98% (HPLC)

别名:

3-((6-(4,5-Dihydro-1H-benzo[d]azepin-3(2H)-yl)-2-(pyridin-2-yl)pyrimidin-4-yl)amino)propanoic acid; N-[2-(2-pyridinyl)-6-(1,2,4,5-tetrahydro-3H-3-benzazepin-3-yl)-4-pyrimidinyl]-β-Alanine

登录查看公司和协议定价

所有图片(1)

About This Item

经验公式（希尔记法）:

C₂₂H₂₃N₅O₂

CAS号:

1373422-53-7

分子量:

389.45

MDL编号:

MFCD22683851

UNSPSC代码:

12352202

PubChem化学物质编号:

329825587

NACRES:

NA.77

推荐产品

Slide 1 of 10

1 of 10

Sigma-Aldrich

SML0701

GSK-J4

Sigma-Aldrich

SML1072

GSK-LSD1

Sigma-Aldrich

420205

Histone Lysine Demethylase Inhibitor VIII, GSK-J4

Sigma-Aldrich

SML0766

GSK343

Sigma-Aldrich

SML1133

SGC-CBP30

Sigma-Aldrich

SML0559

LDN193189 盐酸盐

Sigma-Aldrich

X3004

XAV939

Sigma-Aldrich

5.05052

Ezh2/Ezh1 Inhibitor, UNC1999

Sigma-Aldrich

S4317

SB 431542 水合物

Sigma-Aldrich

A5503

白蛋白来源于鸡蛋白

质量水平

100

方案

≥98% (HPLC)

表单

powder

颜色

white to beige

溶解性

DMSO: 15 mg/mL, clear

储存温度

2-8°C

SMILES字符串

OC(CCNC1=CC(N2CCC(C=CC=C3)=C3CC2)=NC(C4=CC=CC=N4)=N1)=O

InChI

1S/C22H23N5O2/c28-21(29)8-12-24-19-15-20(26-22(25-19)18-7-3-4-11-23-18)27-13-9-16-5-1-2-6-17(16)10-14-27/h1-7,11,15H,8-10,12-14H2,(H,28,29)(H,24,25,26)

InChI key

AVZCPICCWKMZDT-UHFFFAOYSA-N

应用

GSK-J1 has been used in formaldehyde dehydrogenase (FDH)-coupled demethylase assay.

生化/生理作用

GSK-J1 is a potent selective jumonji H3K27 demethylase inhibitor.

GSK-J1 is a potent selective jumonji H3K27 demethylase inhibitor. Jumonji C domain-containing histone demethylases (JHDMs) are Fe(II) and α-ketoglutarate dependent enzymes that oxygenate methylated histone lysine residues and thereby cause their demethylation. GSK-J1 is selective for the KDM6 subfamily members JMJD3 and UTX with an IC₅₀ of 60 nM in a JMJD3 assay, and is inactive against other demethylases of the JMJ family and over 100 tested kinases and histone deacetylases. For full characterization details, please visit the GSK-J1 probe summary on the Structural Genomics Consortium (SGC) website.

To learn about other SGC chemical probes for epigenetic targets, visit sigma.com/sgc

GSK-J1 is also termed as 3-((6-(4,5-Dihydro-1H-benzo[d]azepin-3(2H)-yl)-2-(pyridin-2-yl)pyrimidin-4-yl)amino)propanoate. It may disturb the differentiation of specific neuronal subtypes in growing rat retina.

特点和优势

GSK-J1 is an epigenetic chemical probe available through a partnership with the Structural Genomics Consortium (SGC). To learn more and view other SGC epigenetic probes, visit sigma.com/SGC.

This compound is a featured product for Gene Regulation research. Click here to discover more featured Gene Regulation products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.

储存分类代码

11 - Combustible Solids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

The Inhibitor Index: A Desk Reference on Enzyme Inhibitors, Receptor Antagonists, Drugs, Toxins, Poisons, Biologics, and Therapeutic Leads, 1362-1362 (2017)

Small Molecule GSK-J1 Affects Differentiation of Specific Neuronal Subtypes in Developing Rat Retina.

Raeisossadati R, et al.

Molecular Neurobiology, 1-12 (2018)

Congenital Hyperinsulinism in Infants with Turner Syndrome: Possible Association with Monosomy X and KDM6A Haploinsufficiency.

Christopher E Gibson et al.

Hormone research in paediatrics, 89(6), 413-422 (2018-06-15)

Previous case reports have suggested a possible association of congenital hyperinsulinism with Turner syndrome. We examined the clinical and molecular features in girls with both congenital hyperinsulinism and Turner syndrome seen at The Children's Hospital of Philadelphia (CHOP) between 1974

Characterization of a linked Jumonji domain of the KDM5/JARID1 family of histone H3 lysine 4 demethylases.

Horton JR, et al.

The Journal of Biological Chemistry, 291(6), 2631-2646 (2016)

An epitranscriptomic mechanism underlies selective mRNA translation remodelling in melanoma persister cells.

Shensi Shen et al.

Nature communications, 10(1), 5713-5713 (2019-12-18)

Cancer persister cells tolerate anticancer drugs and serve as the founders of acquired resistance and cancer relapse. Here we show that a subpopulation of BRAFV600 mutant melanoma cells that tolerates exposure to BRAF and MEK inhibitors undergoes a reversible remodelling

查看所有相关文献

商品

Discover Bioactive Small Molecules for Gene Regulation

We offer a variety of small molecule research tools, such as transcription factor modulators, inhibitors of chromatin modifying enzymes, and agonists/antagonists for target identification and validation in gene regulation research; a selection of these research tools is shown below.

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门

主要文件

GSK-J1

≥98% (HPLC)

About This Item

推荐产品

属性

质量水平

方案

表单

颜色

溶解性

储存温度

SMILES字符串

InChI

InChI key

相关类别

说明

应用

生化/生理作用

特点和优势

相关产品

相关产品

安全信息

储存分类代码

WGK

闪点(°F)

闪点(°C)

文件

分析证书(COA)

已有该产品？

同行评审论文

技术文章和实验方案

商品

技术服务